Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kenneth D. Marshall, Arthur R. Derse, Scott G. Weiner & Joshua W. Joseph. (2023) Revive and Refuse: Capacity, Autonomy, and Refusal of Care After Opioid Overdose. The American Journal of Bioethics 0:0, pages 1-14.
Read now
Read now
Roy Purssell, Jesse Godwin, Jessica Moe, Jane Buxton, Alexis Crabtree, Andrew Kestler, Chris DeWitt, Frank Scheuermeyer, Shannon Erdelyi, Robert Balshaw, Adrianna Rowe, Christopher K. Cochrane, Benjamin Ng, Andy Jiang, Alessia Risi, Vi Ho & Jeffrey R. Brubacher. (2021) Comparison of rates of opioid withdrawal symptoms and reversal of opioid toxicity in patients treated with two naloxone dosing regimens: a retrospective cohort study. Clinical Toxicology 59:1, pages 38-46.
Read now
Read now
Felicia Wong, Christopher J. Edwards, Daniel H. Jarrell & Asad E. Patanwala. (2019) Comparison of lower-dose versus higher-dose intravenous naloxone on time to recurrence of opioid toxicity in the emergency department. Clinical Toxicology 57:1, pages 19-24.
Read now
Read now
Jeremiah M. Kinsman & Kathy Robinson. (2018) National Systematic Legal Review of State Policies on Emergency Medical Services Licensure Levels' Authority to Administer Opioid Antagonists. Prehospital Emergency Care 22:5, pages 650-654.
Read now
Read now
Michael W. Willman, David B. Liss, Evan S. Schwarz & Michael E. Mullins. (2017) Do heroin overdose patients require observation after receiving naloxone?. Clinical Toxicology 55:2, pages 81-87.
Read now
Read now
Yulia V. Krayeva, Konstantin M. Brusin, Alexander V. Bushuev, Dmitriy L. Kondrashov, Valentin G. Sentsov & Knut Erik Hovda. (2013) Pre-hospital management and outcome of acute poisonings by ambulances in Yekaterinburg, Russia. Clinical Toxicology 51:8, pages 752-760.
Read now
Read now
Mark T. Steele, Mark Steele, Ellen J. Westdorp, Alex G. Garza, O. John Ma, David K. Roberts & William A. Watson. (2000) Screening for Stimulant Use in Adult Emergency Department Seizure Patients. Journal of Toxicology: Clinical Toxicology 38:6, pages 609-613.
Read now
Read now
Articles from other publishers (25)
Fergal M. McDermott, Andrea E. Henriksson & Tina A. Wismer. (2021) Heroin intoxication in a dog. Veterinary Record Case Reports 9:3.
Crossref
Crossref
Mohammad Karamouzian, Margot Kuo, Alexis Crabtree & Jane A Buxton. (2019) Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program. International Journal of Drug Policy 71, pages 157-163.
Crossref
Crossref
John Strang, Rebecca McDonald, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Alison Ritter & Ola Dale. (2019) Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine. Drugs 79:13, pages 1395-1418.
Crossref
Crossref
James D. Heaton, Bikash Bhandari, Kiran A. Faryar & Martin R. Huecker. (2019) Retrospective Review of Need for Delayed Naloxone or Oxygen in Emergency Department Patients Receiving Naloxone for Heroin Reversal. The Journal of Emergency Medicine 56:6, pages 642-651.
Crossref
Crossref
Jennifer Anne Greene, Brent J Deveau, Justine S Dol & Michael B Butler. (2019) Incidence of mortality due to rebound toxicity after ‘treat and release’ practices in prehospital opioid overdose care: a systematic review. Emergency Medicine Journal 36:4, pages 219-224.
Crossref
Crossref
Saumitra V. Rege, Duc Anh Ngo, Nassima Ait-Daoud, Sana Sharma, Evan Verplancken & Christopher P. Holstege. (2018) Trends and characteristics of naloxone therapy reported to US poison centers. Addiction 113:12, pages 2309-2315.
Crossref
Crossref
Rachael Rzasa Lynn & JL Galinkin. (2017) Naloxone dosage for opioid reversal: current evidence and clinical implications. Therapeutic Advances in Drug Safety 9:1, pages 63-88.
Crossref
Crossref
Jon B. Cole & Lewis S. Nelson. (2017) Controversies and carfentanil: We have much to learn about the present state of opioid poisoning. The American Journal of Emergency Medicine 35:11, pages 1743-1745.
Crossref
Crossref
Daniel Kolinsky, Samuel M. Keim, Brian G. Cohn, Evan S. Schwarz & Donald M. Yealy. (2017) Is a Prehospital Treat and Release Protocol for Opioid Overdose Safe?. The Journal of Emergency Medicine 52:1, pages 52-58.
Crossref
Crossref
Sharon L. Walsh, Paul A. Nuzzo, Shanna Babalonis, Victoria Casselton & Michelle R. Lofwall. (2016) Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusers. Drug and Alcohol Dependence 162, pages 190-198.
Crossref
Crossref
S.S. Rudolph, G. Jehu, S. Louman Nielsen, K. Nielsen, V. Siersma & L.S. Rasmussen. (2011) Prehospital treatment of opioid overdose in Copenhagen—Is it safe to discharge on-scene?. Resuscitation 82:11, pages 1414-1418.
Crossref
Crossref
A. FareedS. StoutJ. CasarellaS. VayalapalliJ. CoxK. Drexler. (2011) Illicit Opioid Intoxication: Diagnosis and Treatment. Substance Abuse: Research and Treatment 5, pages SART.S7090.
Crossref
Crossref
Simon F. J. Clarke, Rob Török, Paul I. Dargan & Alison L. Jones. 2009. Opiate Receptors and Antagonists. Opiate Receptors and Antagonists
511
539
.
Fridtjof Heyerdahl, Knut E Hovda, Mari A Bjornaas, Anne K Nore, Jose CP Figueiredo, Oivind Ekeberg & Dag Jacobsen. (2008) Pre-hospital treatment of acute poisonings in Oslo. BMC Emergency Medicine 8:1.
Crossref
Crossref
Norberto A. Francisco. (2012) Control of breathing: how to better understand the respiratory effects of opioids. European Journal of Pain Supplements 1:S1, pages 61-65.
Crossref
Crossref
J. J. Boyd, M. J. Kuisma, A. O. Alaspää, E. Vuori, J. V. Repo & T. T. Randell. (2006) Recurrent opioid toxicity after pre‐hospital care of presumed heroin overdose patients. Acta Anaesthesiologica Scandinavica 50:10, pages 1266-1270.
Crossref
Crossref
Keith Henry & Carson R. Harris. (2006) Deadly Ingestions. Pediatric Clinics of North America 53:2, pages 293-315.
Crossref
Crossref
Catherine T. Baca & Kenneth J. Grant. (2005) Take‐home naloxone to reduce heroin death. Addiction 100:12, pages 1823-1831.
Crossref
Crossref
Declan Walsh, Nilo I. Rivera, Mellar P. Davis, Ruth Lagman & Susan B. LeGrand. (2004) Strategies for Pain Management: Cleveland Clinic Foundation Guidelines for Opioid Dosing for Cancer Pain. Supportive Cancer Therapy 1:3, pages 157-164.
Crossref
Crossref
Ingebjørg Buajordet, Anne-Cathrine Næss, Dag Jacobsen & Odd Brørs. (2004) Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. European Journal of Emergency Medicine 11:1, pages 19-23.
Crossref
Crossref
Aaron B. Schneir, Tyler F. Vadeboncoeur, Steven R. Offerman, James D. Barry, Binh T. Ly, Saralyn R. Williams & Richard F. Clark. (2002) Massive OxyContin ingestion refractory to naloxone therapy. Annals of Emergency Medicine 40:4, pages 425-428.
Crossref
Crossref
. 2001. Dreisbach's Handbook of Poisoning. Dreisbach's Handbook of Poisoning
390
421
.
Jeremy Etherington, James Christenson, Grant Innes, Eric Grafstein, Sarah Pennington, John J. Spinelli, Min Gao, Brian Lahiffe, Karen Wanger & Christopher Fernandes. (2015) Is early discharge safe after naloxone reversal of presumed opioid overdose?. CJEM 2:03, pages 156-162.
Crossref
Crossref
Anthony L Vaccarino, Gayle A Olson, Richard D Olson & Abba J Kastin. (1999) Endogenous opiates: 1998☆. Peptides 20:12, pages 1527-1574.
Crossref
Crossref
Ike Eriator. (1998) Narcotic analgesics for chronic pain management. Current Review of Pain 2:4, pages 193-200.
Crossref
Crossref